drugset / Trial / NCT02975297
Exenatide Once Weekly for Smoking Cessation
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to identify a potential new treatment for smoking cessation.
Timeline
- Start
- 2016-07
- Primary completion
- 2020-01-03
- Completion
- 2020-01-03
Publications
- Background Yammine L, Kosten TR, Cinciripini PM, Green CE, Meininger JC, Minnix JA, Newton TF. Exenatide once weekly for smoking cessation: study protocol for a randomized clinical trial. Medicine (Baltimore). 2018 Jan;97(2):e9567. doi: 10.1097/MD.0000000000009567.
- Yammine L, Green CE, Kosten TR, de Dios C, Suchting R, Lane SD, Verrico CD, Schmitz JM. Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial. Nicotine Tob Res. 2021 Aug 29;23(10):1682-1690. doi: 10.1093/ntr/ntab066.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 2 mg | Subcutaneous |
| Background | Nicotine | Unknown | 21 mg | Other |
Indications
No indication recorded.